IPP Bureau
Alkem Labs posts highest-ever EBITDA in FY26; Q4 revenue rises 14.6%
By IPP Bureau - May 29, 2026
Strong domestic and international growth, improving product mix, and operational efficiencies drive margin expansion despite exceptional charges impacting quarterly profit
Supreme Court declares right to trauma care part of Article 21 in landmark judgement
By IPP Bureau - May 29, 2026
The ruling comes against the backdrop of a mounting trauma burden in India, where nearly 4.67 lakh accidental deaths occur annually
Lupin's novel cancer therapy LNP8701 shows encouraging results in phase 1 trial
By IPP Bureau - May 29, 2026
First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
Abbott secures CE mark for first dual glucose-ketone monitoring systems
By IPP Bureau - May 29, 2026
Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk
Solvay and Pantys deepen partnership to expand menstrual health access
By IPP Bureau - May 29, 2026
Solvay will fund Pantys-led initiatives targeting vulnerable communities through product donations and menstrual health education programs
Eli Lilly secures full PBM coverage for obesity drug portfolio expanding access to millions
By IPP Bureau - May 29, 2026
The move marks one of the most significant coverage expansions yet in obesity care, bringing FDA-approved treatment options further into mainstream insurance plans rather than out-of-pocket reach
AbbVie wins FDA nod for DECNUPAZ in rare blood cancer
By IPP Bureau - May 29, 2026
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
Indian scientists develop AI-enabled tech for biomedical diagnostic applications
By IPP Bureau - May 28, 2026
The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention
Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge
By IPP Bureau - May 28, 2026
The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient
Cadila Pharma launches Subhadra Syrup for menstrual health support
By IPP Bureau - May 28, 2026
The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
Teen neuroscience researcher turns ADHD struggles into startup innovation
By IPP Bureau - May 28, 2026
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
Asahi Kasei bags breakthrough ADC tech in push for safer & more precise cancer therapies
By IPP Bureau - May 28, 2026
The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
Hikal swings back to profit in Q4 FY26 despite regulatory hit & strategic charges
By IPP Bureau - May 28, 2026
Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments
Novo Nordisk to showcase late-stage pipeline & semaglutide expansion at ADA 2026
By IPP Bureau - May 28, 2026
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Supriya Lifescience posts 50% revenue growth in Q4 FY26; PAT rises to Rs 74 crore
By IPP Bureau - May 28, 2026
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
